The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
- PMID: 17210786
- PMCID: PMC1759898
- DOI: 10.1101/gad.1487307
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
Abstract
Here we report that RNA interference against ATM inhibited p53 accumulation in cells expressing oncogenic STAT5 and cooperated with Rb inactivation to suppress STAT5A-induced senescence. Knocking down ATM was also effective to bypass E2F1-induced senescence and in combination with Rb inactivation, inhibited RasV12-induced senescence. Cells that senesced in response to ca-STAT5A or RasV12 accumulated DNA damage foci and activated ATM, ATR, Chk1, and Chk2, indicating that aberrant oncogene activation induces a DNA damage signaling response. Intriguingly, bypassing oncogene-induced senescence by inactivation of p53 and Rb did not eliminate the accumulation of oncogene-induced DNA damage foci (ODDI), suggesting a mechanism that may limit transformation in immortalized cells.
Figures
Comment in
-
Oncogenes and senescence: breaking down in the fast lane.Genes Dev. 2007 Jan 1;21(1):1-5. doi: 10.1101/gad.1514207. Genes Dev. 2007. PMID: 17210783 Review. No abstract available.
References
-
- Bakkenist C.J., Kastan M.B., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421:499–506. - PubMed
-
- Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Guldberg P., Sehested M., Nesland J.M., Lukas C., Sehested M., Nesland J.M., Lukas C., Nesland J.M., Lukas C., Lukas C., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864–870. - PubMed
-
- Bowman T., Garcia R., Turkson J., Jove R., Garcia R., Turkson J., Jove R., Turkson J., Jove R., Jove R. STATs in oncogenesis. Oncogene. 2000;19:2474–2488. - PubMed
-
- di d’Adda Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P., Saretzki G., Carter N.P., Jackson S.P., Carter N.P., Jackson S.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003;426:194–198. - PubMed
-
- Dannenberg J.H., van Rossum A., Schuijff L., te Riele H., van Rossum A., Schuijff L., te Riele H., Schuijff L., te Riele H., te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes & Dev. 2000;14:3051–3064. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous